Immune modulating therapies for idiopathic inflammatory bowel diseases. 1994

D S Levine
Department of Medicine, University of Washington, Seattle 98195.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015212 Inflammatory Bowel Diseases Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS. Bowel Diseases, Inflammatory,Inflammatory Bowel Disease

Related Publications

D S Levine
August 2009, Expert review of gastroenterology & hepatology,
D S Levine
January 2016, Digestive diseases (Basel, Switzerland),
D S Levine
April 2009, Gastroenterology,
D S Levine
December 1992, Zeitschrift fur arztliche Fortbildung,
D S Levine
October 2009, Journal of gastroenterology and hepatology,
D S Levine
December 2016, Current gastroenterology reports,
D S Levine
January 2014, Current drug targets,
D S Levine
June 2015, MMW Fortschritte der Medizin,
D S Levine
January 1994, Acta gastro-enterologica Belgica,
D S Levine
January 1997, Inflammatory bowel diseases,
Copied contents to your clipboard!